Authors:
LING NR
HARDIE DL
JOHNSON GD
MACLENNAN ICM
Citation: Nr. Ling et al., ORIGIN AND PROPERTIES OF SOLUBLE CD21 (CR-2) IN HUMAN BLOOD, Clinical and experimental immunology, 113(3), 1998, pp. 360-366
Citation: Nr. Ling et al., PRODUCTION OF IMMUNOGLOBULINS BY HUMAN SIGD(-) HUMAN BLOOD B-LYMPHOCYTES IN RESPONSE TO STIMULATION WITH ACTIVATED T-CELLS AND AGONISTIC ANTIBODIES - EFFECT OF IL-10, IL-2 AND MODE OF ACTIVATION OF T-CELLS() AND SIGD(), Clinical and experimental immunology, 101(2), 1995, pp. 369-375
Authors:
FLAVELL DJ
FLAVELL SU
BOEHM DA
EMERY L
NESS A
LING NR
RICHARDSON PR
HARDIE D
WRIGHT DH
Citation: Dj. Flavell et al., PRECLINICAL STUDIES WITH THE ANTI-CD19-SAPORIN IMMUNOTOXIN BU12-SAPORIN FOR THE TREATMENT OF HUMAN-B-CELL TUMORS, British Journal of Cancer, 72(6), 1995, pp. 1373-1379
Citation: Nr. Ling et al., SYNERGY TEST FOR RECOGNITION OF EPITOPES ON SOLUBLE-PROTEINS - ITS APPLICATION IN THE STUDY OF CD21 AND CD23 ANTIGENS AND THEIR RESPECTIVE ANTIBODIES, Journal of immunological methods, 173(1), 1994, pp. 11-17
Citation: Nr. Ling et Jl. Lowe, IS THE ACTIVATED T-HELPER STIMULUS ABLE TO INDUCE IG ISOTYPE SWITCHING IN CULTURED HUMAN B-CELLS, International immunology, 5(10), 1993, pp. 1269-1273
Citation: Nr. Ling et Jl. Lowe, EFFICIENCY OF INDUCTION OF IMMUNOGLOBULIN-SYNTHESIS BY AUTOLOGOUS HUMAN T-CELLS AND T-CELL CLONES - RELATION TO SURFACE ISOTYPE OF THE B-CELL, Immunobiology, 189(5), 1993, pp. 436-447
Citation: Nr. Ling, PITFALLS IN THE MEASUREMENT OF SOLUBLE FORMS OF CELL-SURFACE RECEPTORS, Clinical and experimental immunology, 93(2), 1993, pp. 139-141